PTCH1 and neoplasm: The genomic instability resulting from ablation of these tumor suppressors drives MB development through the amplification of MYCN and PTCH2, an isoform of the frequently mutated PTCH1 of SHH MB possessing smoothened inhibitory features (137, 138).